Carregant...
Aliskiren as an adjunct therapy for atypical hemolytic uremic syndrome
Direct renin inhibitors (DRIs) block the activation of the alternative complement pathway in vitro and could be a treatment option for refractory hypertension in atypical hemolytic uremic syndrome (aHUS). A 20-year-old male presented with primary aHUS complicated by end-stage renal disease and refra...
Guardat en:
| Publicat a: | Clin Kidney J |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7025342/ https://ncbi.nlm.nih.gov/pubmed/32083614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfz146 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|